Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer's disease model

Neurobiology of Aging

Volumn 24, Issue 3, 2003, Pages 397-413

  Link, Christopher D ^a   Taft, Andrew ^a   Kapulkin, Vadim ^a   Duke, Kyle ^b   Kim, Stuart ^b   Fei, Qing ^c   Wood, Douglas E ^c   Sahagan, Barbara G ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Alzheimer; A 42; Caenorhabditis elegans; Inducible expression; Microarray; Quantitative RT PCR; Transgenic

Indexed keywords

ALPHA B CRYSTALLIN; ALPHA CRYSTALLIN; AMYLOID BETA PROTEIN; COMPLEMENTARY DNA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR INDUCED PROTEIN 1; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN TISSUE; CADAVER; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA MICROARRAY; DNA PROBE; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE INDUCTION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; STATISTICAL ANALYSIS; TRANSGENE; TRANSGENIC ANIMAL;

CAENORHABDITIS ELEGANS;

EID: 0037405291     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(02)00224-5     Document Type: Article

References (34)

1. Aravind L., Koonin E.V. Fold prediction and evolutionary analysis of the POZ domain: structural and evolutionary relationship with the potassium channel tetramerization domain. J. Mol. Biol. 285:1999;1353-1361.
2. Askanas V., Engel W.K. Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease. J. Neuropathol. Exp. Neurol. 60:2001;1-14.
3. Ausebel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, et al., editors. Current protocols in molecular biology. 1998. p. 4.2.5-4.9.
4. Banwell B.L., Engel A.G. AlphaB-crystallin immunolocalization yields new insights into inclusion body myositis. Neurology. 54:2000;1033-1041.
5. Barger S.W., Horster D., Furukawa K., Goodman Y., Krieglstein J., Mattson M.P. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc. Natl. Acad. Sci. USA. 92:1995;9328-9332.
6. Cole K.E., Strick C.A., Paradis T.J., Ogborne K.T., Loetscher M., Gladue R.P.et al. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 187:1998;2009-2021.
7. Dixit V.M., Green S., Sarma V., Holzman L.B., Wolf F.W., O'Rourke K.et al. Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J. Biol. Chem. 265:1990;2973-2978.
8. Fay D.S., Fluet A., Johnson C.J., Link C.D. In vivo aggregation of beta-amyloid peptide variants. J. Neurochem. 71:1998;1616-1625.
9. Fonte V., Kapulkin K., Taft A., Fluet A., Friedman D., Link C.D. Interaction of intracellular beta amyloid peptide with chaperone proteins. Proc. Natl. Acad. Sci. USA. 99(14):2002;9439-9444.
10. Ginsberg S.D., Hemby S.E., Lee V.M., Eberwine J.H., Trojanowski J.Q. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann. Neurol. 48:2000;77-87.
11. Gouras G.K., Tsai J., Naslund J., Vincent B., Edgar M., Checler F.et al. Intraneuronal Abeta42 accumulation in human brain. Am. J. Pathol. 156:2000;15-20.
12. Gu Z., Flemington C., Chittenden T., Zambetti G.P. ei24, a p53 response gene involved in growth suppression and apoptosis. Mol. Cell Biol. 20:2000;233-241.
13. Hata R., Masumura M., Akatsu H., Li F., Fujita H., Nagai Y.et al. Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray. Biochem. Biophys. Res. Commun. 284:2001;310-316.
14. Kawarabayashi T., Shoji M., Sato M., Sasaki A., Ho L., Eckman C.B.et al. Accumulation of beta-amyloid fibrils in pancreas of transgenic mice. Neurobiol. Aging. 17:1996;215-222.
15. Kienlen-Campard P., Miolet S., Tasiaux B., Octave J.N. Intracellular amyloid-beta 1-42, but not extracellular soluble amyloid-beta peptides, induces neuronal apoptosis. J. Biol. Chem. 277:2002;15666-15670.
16. Kim S.K., Lund J., Kiraly M., Duke K., Jiang M., Stuart J.M.et al. A gene expression map for Caenorhabditis elegans. Science. 293:2001;2087-2092.
17. Kuret J., Johnson G.S., Cha D., Christenson E.R., DeMaggio A.J., Hoekstra M.F. Casein kinase 1 is tightly associated with paired-helical filaments isolated from Alzheimer's disease brain. J. Neurochem. 69:1997;2506-2515.
18. Lewis JA, Fleming JT. In: Epstein HF, Shakes DC, editors. Caenorhabditis elegans: Modern Biological Analysis of a Model Organism. New York: Academic Press; 1996. p. 3-29.
19. Link C.D. Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA. 92:1995;9368-9372.
20. Link C.D., Cypser J.R., Johnson C.J., Johnson T.E. Direct observation of stress response in Caenorhabditis elegans using a reporter transgene. Cell Stress Chaperones. 4:1999;235-242.
21. Link C.D., Johnson C.J., Fonte V., Paupard M., Hall D.H., Styren S.et al. Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34. Neurobiol. Aging. 22:2001;217-226.
22. Loring J.F., Wen X., Lee J.M., Seilhamer J., Somogyi R. A gene expression profile of Alzheimer's disease. DNA Cell Biol. 20:2001;683-695.
23. Mango S.E. Stop making nonSense: the C. elegans smg genes. Trends Genet. 17:2001;646-653.
24. Martin S.J., Reutelingsperger C.P., McGahon A.J., Rader J.A., van Schie R.C., LaFace D.M.et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Aβl. J. Exp. Med. 182:1995;1545-1556.
25. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., Jones P.K.et al. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60:2001;759-767.
26. Pasinetti G.M. Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia. J. Neurosci. Res. 65:2001;471-476.
27. Reinke V., Smith H.E., Nance J., Wang J., Van Doren C., Begley R.et al. A global profile of germline gene expression in C. elegans. Mol. Cell. 6:2000;605-616.
28. Renkawek K., Voorter C.E., Bosman G.J., van Workum F.P., de Jong W.W. Expression of alpha B-crystallin in Alzheimer's disease. Acta Neuropathol. (Berl). 87:1994;155-160.
29. Schwab C., DeMaggio A.J., Ghoshal N., Binder L.I., Kuret J., McGeer P.L. Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases. Neurobiol. Aging. 21:2000;503-510.
30. Selkoe D.J. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann. NY Acad. Sci. 924:2000;17-25.
31. Shinohara H., Inaguma Y., Goto S., Inagaki T., Kato K. Alpha B crystallin and HSP28 are enhanced in the cerebral cortex of patients with Alzheimer's disease. J. Neurol. Sci. 119:1993;203-208.
32. Sugarman M.C., Yamasaki T.R., Oddo S., Echegoyen J.C., Murphy M.P., Golde T.E.et al. Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle. Proc. Natl. Acad. Sci. USA. 99:2002;6334-6339.
33. Walker D.G., Lue L.F., Beach T.G. Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia. Neurobiol. Aging. 22:2001;957-966.
34. Walsh D.M., Tseng B.P., Rydel R.E., Podlisny M.B., Selkoe D.J. The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Biochemistry. 39:2000;10831-10839.